Whirlpool Corporation (WHR)

Theseus Pharmaceuticals Stock Forecast

Stock Price Forecast

The 6 analysts that cover Theseus Pharmaceuticals stock have a consensus rating of "Hold" and an average price target of $98.83, which forecasts a 18.01% increase in the stock price over the next year. The lowest target is $63 and the highest is $145.

Price Target: $98.83 (+18.01%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$63	$98.83	$89	$145
Change	-24.78%	+18.01%	+6.27%	+73.13%

Analyst Ratings

The average analyst rating for Theseus Pharmaceuticals stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Mar '25	Apr '25	May '25	Jun '25	Jul '25	Aug '25
Strong Buy	2	1	1	2	2	2
Buy	0	0	0	0	0	0
Hold	1	1	1	2	1	2
Sell	2	2	2	1	2	2
Strong Sell	0	0	0	0	0	0
Total	5	4	4	5	5	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jeffrey Stevenson Loop Capital	Loop Capital	Hold Initiates $88	Hold	Initiates	$88	+5.07%	Aug 4, 2025
Mike Dahl RBC Capital	RBC Capital	Sell Maintains $65 → $63	Sell	Maintains	$65 → $63	-24.78%	Jul 30, 2025
Rafe Jadrosich B of A Securities	B of A Securities	Hold → Sell Downgrades $100 → $70	Hold → Sell	Downgrades	$100 → $70	-16.42%	Jul 29, 2025
David Macgregor Longbow Research	Longbow Research	Hold → Strong Buy Upgrades $145	Hold → Strong Buy	Upgrades	$145	+73.13%	Jun 30, 2025
Rafe Jadrosich B of A Securities	B of A Securities	Sell → Hold Upgrades $68 → $94	Sell → Hold	Upgrades	$68 → $94	+12.24%	Jun 13, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

15.82B

Decreased by -4.76%

from 16.61B

Revenue Next Year

15.95B

Increased by 0.83%

from 15.82B

EPS This Year

9.32

from -5.87

EPS Next Year

11.08

Increased by 18.88%

from 9.32

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	19.46B	21.99B	19.72B	19.46B	16.61B	15.82B	15.95B	16.80B
Revenue Growth	-4.72%	13.00%	-10.28%	-1.36%	-14.64%	-4.76%	0.83%	5.36%
EPS	16.98	28.36	-27.18	8.72	-5.87	9.32	11.08	13.47
EPS Growth	-6.65%	67.02%	-	-	-	-	18.88%	21.56%
Forward PE	-	-	-	-	-	8.98	7.56	6.22
No. Analysts	-	-	-	-	-	13	13	7

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	16.8B	17.2B	17.7B
Avg	15.8B	15.9B	16.8B
Low	15.1B	14.9B	15.9B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	1.2%	8.6%	10.9%
Avg	-4.8%	0.8%	5.4%
Low	-9.0%	-5.7%	-0.6%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	10.71	13.98	15.73
Avg	9.32	11.08	13.47
Low	7.56	8.95	10.78

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	49.9%	41.9%
Avg	-	18.9%	21.6%
Low	-	-4.0%	-2.7%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.